Domov › Rak dojke › Virginia › Arlington
Klinične študije za Rak dojke v Arlington, VA
47 študij za Rak dojke išče udeležence na lokacijah v Arlington in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
The Vanguard Study: Testing a New Way to Screen for Cancer
Vključevanje udeležencevVabljeni zdravi prostovoljci
- Inova Schar Cancer Institute, Fairfax · 11 mi stran
- Inova Fair Oaks Hospital, Fairfax · 11 mi stran
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Vključevanje udeležencevFaza 3
- Virginia Cancer Specialists, PC, Fairfax · 11 mi stran
A Study of PHST001 in Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT Oncology - Virginia, Fairfax · 11 mi stran
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Vključevanje udeležencevFaza 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi stran
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
Vključevanje udeležencevFaza 2
- Virginia Cancer Specialists, Fairfax · 11 mi stran
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Vključevanje udeležencevFaza 1/2
- Inova Schar Cancer Institute, Fairfax · 11 mi stran
- Virginia Cancer Specialists, PC, Fairfax · 11 mi stran
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
Vključevanje udeležencevFaza 2
- Inova Schar Cancer Institute, Fairfax · 11 mi stran
Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy
Vključevanje udeležencevFaza 3
- Inova Schar Cancer Institute, Fairfax · 11 mi stran
Study of AVZO-021 in Patients With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- Avenzo Therapeutics Recruiting Site, Fairfax · 11 mi stran
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Vključevanje udeležencevFaza 3
- Inova Schar Cancer Institute ( Site 0025), Fairfax · 11 mi stran
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Vključevanje udeležencevFaza 3
- Research Site, Fairfax · 11 mi stran
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Vključevanje udeležencevFaza 2
- Virginia Cancer Specialists, Fairfax · 11 mi stran
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Vključevanje udeležencev
- Inova, Fairfax · 11 mi stran
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Vključevanje udeležencevFaza 3
- Virginia Cancer Specialists, Fairfax · 11 mi stran
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
Vključevanje udeležencevFaza 2
- Inova Schar Cancer Institute, Fairfax · 11 mi stran
A Study of JNJ-101684362 (HLD-0117) in Patients With Metastatic Breast Cancer
Vključevanje udeležencevFaza 1
- Next Virginia, Fairfax · 11 mi stran
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Vključevanje udeležencevFaza 1/2
- NEXT Oncology, Fairfax · 11 mi stran
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Vključevanje udeležencevFaza 3
- Inova Schar Cancer Institute, Fairfax · 11 mi stran
- Virginia Cancer Specialists, Fairfax · 11 mi stran
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Vključevanje udeležencevFaza 1
- Virginia Cancer Specialists, Fairfax · 11 mi stran
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Vključevanje udeležencevFaza 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 mi stran
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT Oncology, Fairfax · 11 mi stran
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
Vključevanje udeležencevFaza 1/2
- Next Oncology, Fairfax · 11 mi stran
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- Virginia Cancer Specialists-Fairfax, Fairfax · 11 mi stran
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
Vključevanje udeležencevFaza 1/2
- NEXT Virginia, Fairfax · 11 mi stran
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Vključevanje udeležencevFaza 3
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 mi stran
- Kaiser Permanente-Burke Medical Center, Burke · 11 mi stran
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT Virginia, Fairfax · 11 mi stran
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT Virginia, Fairfax · 11 mi stran
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- Inova Schar Cancer Institute, Falls Church · 4 mi stran
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Vključevanje udeležencevFaza 3
- Inova Schar Cancer Institute, Fairfax · 11 mi stran
- Inova Fair Oaks Hospital, Fairfax · 11 mi stran
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Vključevanje udeležencevFaza 3
- Virginia Cancer Specialists, Fairfax · 11 mi stran
E-Mindfulness Approaches for Living After Breast Cancer
Vključevanje udeležencevFaza 3
- Inova Fairfax Hospital, Falls Church · 4 mi stran
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 mi stran
- Inova Schar Cancer Institute, Fairfax · 11 mi stran
- in še 1
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Vključevanje udeležencevFaza 1/2
- USOR Virginia Cancer Specialists, Fairfax · 11 mi stran
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT Virginia, Fairfax · 11 mi stran
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- USO-Virginia Cancer Specialists, PC, Fairfax · 11 mi stran
Pre-Operative Window of ET to Inform RT Decisions (POWER II)
Vključevanje udeležencevFaza 3
- INOVA Schar Cancer, Fairfax · 11 mi stran
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
Vključevanje udeležencevFaza 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi stran
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- NEXT, Fairfax · 11 mi stran
Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer
Vključevanje udeležencevFaza 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi stran
Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)
Vključevanje udeležencevFaza 1/2
- Inova Schar Cancer Institute ( Site 0051), Fairfax · 11 mi stran
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Vključevanje udeležencevFaza 3
- Virginia Cancer Specialists, PC, Reston · 14 mi stran
- Virginia Cancer Specialists, Manassas · 22 mi stran
A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer
Vključevanje udeležencevFaza 1
- Virginia Cancer Specialists, Fairfax · 11 mi stran
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Vključevanje udeležencevFaza 1
- NEXT Oncology Virginia, Fairfax · 11 mi stran
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
Vključevanje udeležencevFaza 1/2
- NEXT Virginia, Fairfax · 11 mi stran
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
Vključevanje udeležencevFaza 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi stran
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Vključevanje udeležencevFaza 1/2
- NEXT, Virginia, Fairfax · 11 mi stran
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
Vključevanje udeležencevFaza 1
- Inova Schar Cancer Center, Fairfax · 11 mi stran
- NEXT Virginia, Fairfax · 11 mi stran
Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BTX-9341 in Advanced and/or Metastatic Breast Cancer
Vključevanje udeležencevFaza 1
- Biotheryx Investigative Site, Fairfax · 11 mi stran
Študije za Rak dojke v drugih mestih
- New York City, NY136 študij
- Houston, TX126 študij
- Boston, MA112 študij
- Nashville, TN81 študij
- Los Angeles, CA73 študij
- Edison, NJ68 študij
- St. Louis, MO64 študij
- Queens, NY64 študij
- Durham, NC64 študij
- Chicago, IL59 študij
- Philadelphia, PA56 študij
- Dallas, TX55 študij
Druge študije v Arlington
- Nemalicelični pljučni rak104 študij
- Metastatski rak53 študij
- Kolorektalni rak52 študij
- Rak (vse vrste)48 študij
- Rak jajčnikov46 študij
- Rak pljuč41 študij
- Rak endometrija39 študij
- Rak trebušne slinavke33 študij
- Ploščatocelični karcinom glave in vratu26 študij
- Mikrocitni rak pljuč23 študij
- Rak želodca20 študij
- Trojno negativni rak dojke20 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.